BridgeBio Pharma Inc (BBIO)
NASDAQ · Biotechnology
Scores are generated from technical indicators for educational purposes and are not a recommendation to buy or sell.
Price history
Daily closes and volumeAI Analysis Generated from the indicator readings below. Educational only.
BridgeBio Pharma Inc is trading at $76.50, down 0.09% on the session. The 50 day average sits at $79.86 and the 200 day at $73.60, which puts the stock in a uptrend. RSI is at 36.8, which reads as weak, and MACD is bearish crossover. Volume is average.
The nearest support is around $65.59 with resistance near $85.65, so that band frames the current range. Average daily movement is roughly $2.69, or about 3.5% of the share price, which is what any stop placement has to allow for. The overall health score of 57 out of 100 combines a trend score of 77, momentum of 27 and a risk score of 65.